Biostatistics: 2013 Annual Conference on Statistical Issues in Clinical Trials

University of Pennsylvania
Center for Clinical Epidemiology and Biostatistics
Department of Biostatistics and Epidemiology
6th Annual Conference on
Statistical Issues in Clinical Trials

April 17, 2013

Topic for 2013 Conference:
Dynamic Treatment Regimes


Biomedical Research Building Auditorium
Biomedical Research Building (BRB II/III)
Perelman School of Medicine
University of Pennsylvania
421 Curie Boulevard
Philadelphia, PA 19104



The 2013 Conference will bring together leading scientists who will discuss state-of-the-art designs and developing methods for evaluating treatment strategies in chronic diseases and conditions when multiple treatments are available and regular changes in treatment are needed and expected. Participants from academic institutions, industry and governmental agencies with an interest in clinical trials in such settings are encouraged to register.


Co-Sponsors:

American Statistical Association - 2013 Annual Meeting Information
Society for Clinical Trials - 2013 Annual Meeting Information
     
Faculty Institution Topic
Phil Lavori Stanford University Introduction to dynamic treatment regimes and SMART designs
Yingqi Zhao University of Wisconsin - Madison Estimation of optimal dynamic treatment regimes
Bibhas Chakraborty Columbia University M-out-of-n bootstrap: A pragmatic inference tool for dynamic treatment regimes
Linda Collins Pennsylvania State University SMART: an integral part of the Multiphase Optimization Strategy (MOST)
Kevin Lynch University of Pennsylvania Two- and three-stage adaptive treatment regimens in substance abuse research
Erica Moodie McGill University Generating candidate optimal individualized dosing strategies
Kelley Kidwell University of Michigan SMART designs in cancer research: Learning from the past, current limitations and issues for the future
Keaven Anderson Merck (commentary) Panelists
Rick Chappell University of Wisconsin - Madison (commentary)
Christy Chuang-Stein Pfizer (commentary)
Dean Follmann National Institute of Allergy and Infectious Diseases (commentary)
Marshall Joffe University of Pennsylvania (commentary)
Michael Kosorok University of North Carolina - Chapel Hill (commentary)
Estelle Russek-Cohen Food and Drug Administration



Agenda:

The latest version of the agenda is available here.

For additional information, contact:
Marissa Fox
Phone: 215-573-2728   Email: mfox@mail.med.upenn.edu



Disclaimer

Funding for this conference was made possible (in part) by 2 R13 CA132565-06 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


Penn Medicine CCEB Home